Skip to main navigation
Skip to search
Skip to main content
University of Hertfordshire (Research Profiles) Home
Search content at University of Hertfordshire (Research Profiles)
Home
Profiles
Research output
Projects
Research units
Beta adrenoreceptor subtype cross regulation in the human heart
J.A. Hall
, A. Ferro
,
Claire Dickerson
, M.J. Brown
Centre for Research in Professional and Work-Related Learning
Schools of Law and Education
Education
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Beta adrenoreceptor subtype cross regulation in the human heart'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cross-regulation
100%
β-adrenoceptor
100%
Beta-blockers
100%
Bisoprolol
100%
Human Heart
100%
Salbutamol
75%
Placebo
50%
Heart Rate
50%
B2 Receptor
50%
Microgram
50%
β2-adrenoceptor
50%
Hypokalemia
25%
Arrhythmia
25%
A1 Receptor
25%
Diastolic Blood Pressure
25%
Blood Glucose
25%
Hyperglycemia
25%
Cross-sensitization
25%
Exercise-induced
25%
Serum Potassium
25%
Serum Insulin
25%
Ischemic Heart Disease
25%
Healthy Volunteers
25%
Adrenoceptors
25%
Placebo-controlled
25%
Controlled Crosses
25%
Treadmill Exercise
25%
Hyperinsulinemia
25%
Medicine and Dentistry
Beta Adrenergic Receptor
100%
Bisoprolol
100%
Beta 2 Adrenergic Receptor
100%
Placebo
75%
Beta 1 Adrenergic Receptor Blocking Agent
75%
Sensitization
75%
Salbutamol
75%
Beta 1 Adrenergic Receptor
50%
Cross Allergy
25%
Isoetarine
25%
Treadmill Exercise
25%
Ischemic Heart Disease
25%
Beta Adrenergic Receptor Blocking Agent
25%
Prospective Study
25%
Hyperglycemia
25%
Cardiac Dysrhythmia
25%
Hyperinsulinemia
25%
Receptor
25%
Diastolic Blood Pressure
25%
Volunteer
25%
Hypokalemia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Bisoprolol
100%
Beta 2 Adrenergic Receptor
100%
Beta Adrenergic Receptor
100%
Beta 1 Adrenergic Receptor Blocking Agent
75%
Placebo
75%
Salbutamol
75%
Beta 1 Adrenergic Receptor
50%
Heart Arrhythmia
25%
Normal Human
25%
Isoetarine
25%
Hypokalemia
25%
Hyperinsulinemia
25%
Hyperglycemia
25%
Ischemic Heart Disease
25%
Cross Allergy
25%
Prospective Study
25%
Beta Adrenergic Receptor Blocking Agent
25%
Receptor
25%
Isotopes of Potassium
25%